Zymeworks competitorsClear all

Zymeworks's top competitors include NovoCure, Asher Bio, Sensei Biotherapeutics and NKMax.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Asher Bio
Asher Bio
Asher Bio (also known as Asher Biotherapeutics) is a biotechnology company developing cis-targeted immunotherapies for cancer and other diseases.
Sensei Biotherapeutics
Sensei Biotherapeutics
Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.
NKMax
NKMax
NKMax America is a company developing cellular therapies that use the power of a patient’s immune system.
Founding Date
Founding Date
2003
Founding Date
2000
Founding Date
2019
Founding Date
1999
Founding Date
2017
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Vancouver, CA HQ
Seattle, US
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Chiyoda City, JP
Root, CH
Malvern, US
New York, US
see more
Locations
South San Francisco, US HQ
Locations
Rockville, US HQ
Boston, US
Locations
Santa Ana, US HQ
Employees
Employees
45519% increase
Employees
1,02331% increase
Employees
373% decrease
Employees
25
Employees
652% increase
Valuation ($)
Valuation ($)
258.4 m
Valuation ($)
7 b
Valuation ($)
N/A
Valuation ($)
45.6 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.2 k
Twitter followers
2.2 k
Twitter followers
124
Twitter followers
193
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
6.7
Average likes per tweet (last 30 days)
1.4
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
90%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
62.5%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
408566
Alexa Website Rank
140879
Alexa Website Rank
337158
Alexa Website Rank
311029
Alexa Website Rank
313817
Employee Rating
Employee Rating
3.2
Employee Rating
3.8
Employee Rating
N/A
Employee Rating
4
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$26.7m (FY, 2021)
Revenue (est.)
$535m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
₩10.4b (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
($104.6m) (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
(₩596.1m) (FY, 2020)
Gross profit
Gross profit
$26.7m (FY, 2021)
Gross profit
$430.4m (FY, 2021)
Gross profit
N/A
Gross profit
N/A
Gross profit
₩9.9b (FY, 2020)
Net income
Net income
($211.8m) (FY, 2021)
Net income
($58.4m) (FY, 2021)
Net income
N/A
Net income
($16.7m) (FY, 2019)
Net income
(₩41.4b) (FY, 2020)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 55m (about 1 year ago)
Latest funding round
N/A
Latest funding round
$ 11m (over 2 years ago)
Total funding raised
Total funding raised
$ 125.9m
Total funding raised
N/A
Total funding raised
$ 55.2m
Total funding raised
$ 28.5m
Total funding raised
$ 11m
For sources of this data, please see the company profile

View company profiles

NovoCure
HQ
Saint Helier, JE
Employees
1,023↑ 31% increase

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

View company
Asher Bio
HQ
South San Francisco, US
Employees
37↓ 3% decrease

Asher Bio (also known as Asher Biotherapeutics) is a biotechnology company developing cis-targeted immunotherapies for cancer and other diseases.

View company
Sensei Biotherapeutics
HQ
Rockville, US
Employees
25

Sensei Biotherapeutics (formerly known as Panacea Pharmaceuticals) is a biotechnology company developing biologics therapies targeting key components of the immune system for the treatment of cancers.

View company
NKMax
HQ
Santa Ana, US
Employees
65↑ 2% increase

NKMax America is a company developing cellular therapies that use the power of a patient’s immune system.

View company